Director, Global Marketing, HCC
BeiGene
Summary
As the Global Marketing Director, HCC, you will play a critical role within BeOne's Global Commercial Strategy & Operations team on the newly-formed HCC Global Brand Team. You will develop and execute marketing strategies that drive long-term success for BGB-B2033, BeOne's first-in-class GPC3x41BB bispecific antibody with transformational potential for advanced and early-stage HCC disease.
Job description
Essential Functions
- Coordinate with cross-functional partners inclusive of Medical Affairs, Insights/Analytics, Pricing/Access and other functional team members to inform integrated global strategies and the resulting Global Brand Plan.
- Support pre-launch preparations of MOA and disease state / unmet need narratives, resulting unbranded campaigns, and initial brand foundations.
- In partnership with Marketing leaders across GBT and other core markets, conceive impactful launch strategies aligned to the overall global strategies and aligned core tactics in the Launch Playbook.
- Drive timely development of marketing deliverables leveraging regional and market feedback.
- Secure GBT endorsement of marketing deliverables and timelines, and ensure on-time launch and execution of key milestones.
- Serve as a global commercial voice and provide marketing thought leadership at key meetings, conferences or other fora such as advisory boards, KOL meetings, and internal Launch Readiness/Launch Optimization meetings.
- Collaborate with key internal and external stakeholders to inform global commercial initiatives and assessments.
- Partner with internal cross-functional teams to develop strategic insights by commissioning and synthesizing primary and secondary research, advisory input and competitive intelligence.
- Act as a cross-functional leader by integrating execution plans across all BeOne functions to drive innovative ideas that can support successful indication launches around the globe.
- Contribute to the Annual Operating Plan (AOP) and Long Range Plan (LRP) processes.
- Manage external partners and associated budget, e.g. the global Agency of Record, in a manner consistent with timeline and budgetary goals.
Qualifications
Bachelor's degree required. Advanced degree preferred. BS with 10+ years, Masters with 7+ years, or a Doctorate with 5+ years of experience in pharmaceutical marketing/healthcare-related commercial experience, inclusive of 5+ years in oncology/hematology. 3+ years of Global Marketing, Regional Marketing, or New Product Planning experience. In-country experience in a major market (US/EU5/Japan/China). Demonstrated experience in leading brand strategy/new product planning at various stages of the product lifecycle, including pre-launch phase. Product launch experience, either from a Global-based role or Market-based role.
Requirements
- Bachelor's degree in Marketing, Sciences, or a related field
- BS with 10+ years, Masters with 7+ years, or Doctorate with 5+ years of pharmaceutical marketing/healthcare-related commercial experience
- 5+ years in oncology/hematology
- 3+ years of Global Marketing, Regional Marketing, or New Product Planning experience
- In-country experience in a major market (US/EU5/Japan/China)
- Demonstrated experience leading brand strategy/new product planning across product lifecycle including pre-launch
- Product launch experience from a Global-based or Market-based role
- Strong team player driving cross-regional and cross-functional alignment
- Proven ability to inspire, motivate and lead high-performing, matrixed teams
- Skilled in engaging, connecting, and influencing across all levels
- Understanding of change management principles and experience driving change
- Ability to work across time zones, geographies, and cultures
- PC skills including MS Office Suite and MS Teams
- Travel up to 20% including international travel
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Incentive Compensation Plan
- Equity Awards
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.